References
1 Bozdag G, Mumusoglu S, Zengin D, Karabulut E YB. The Prevalence and
Phenotypic Features of Polycystic Ovary Syndrome: A Systematic Review
and Meta-Analysis - PubMed. Hum Reprod. 2016;31(12)2841‐2855.
2 Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson
O. Risk of adverse pregnancy outcomes in women with polycystic ovary
syndrome: Population based cohort study. BMJ 2011;343(7828).
3 Wang T, Fu H, Chen L, Xu Y. Pregnancy complications among women with
polycystic ovary syndrome in China: A Meta-analysis. J Cent South Univ
(Medical Sci 2017;42(11):1300–10.
4 Palomba S, De Wilde MA, Falbo A, Koster MPH, La Sala GB, Fauser BCJM.
Pregnancy complications in women with polycystic ovary syndrome. Hum
Reprod Update 2015;21(5):575–92.
5 Taylor HS, Vanden Heuvel GB, Igarashi P. A Conserved Hox Axis in the
Mouse and Human Female Reproductive System: Late Establishment and
Persistent Adult Expression of the Hoxa Cluster Genes. Biol Reprod
1997;57(6):1338–45.
6 Lewis EB. A gene complex controlling segmentation in Drosophila.
Nature. 1978;276(5688):565–70.
7 McGinnis W, Levine MS, Hafen E, Kuroiwa A, Gehring WJ. A conserved DNA
sequence in homoeotic genes of the Drosophila Antennapedia and bithorax
complexes. Nature 1984;308(5958):428–33.
8 McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell.
1992;68(2):283–302.
9 McGinnis W, Garber RL, Wirz J, Kuroiwa A, Gehring WJ. A homologous
protein-coding sequence in drosophila homeotic genes and its
conservation in other metazoans. Cell 1984;37(2):403–8.
10 Mullen RD, Behringer RR. Molecular genetics of Müllerian duct
formation, regression and differentiation. Sex Dev 2014;8(5):281–96.
11 Krumlauf R. Hox genes in vertebrate development. Cell.
1994;78(2):191–201.
12 Block K, Kardana A, Igarashi P, Taylor HS. In utero
diethylstilbestrol (DES) exposure alters Hox gene expression in the
developing mullerian system. FASEB J 2000;14(9):1101–8.
13 Massé J, Watrin T, Laurent A, Deschamps S, Guerrier D, Pellerin I.
The developing female genital tract: From genetics to epigenetics. Int.
J. Dev. Biol. 2009;53(2–3):411–24.
14 Benson G V., Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms
of reduced fertility in Hoxa-10 mutant mice: Uterine homeosis and loss
of maternal Hoxa-10 expression. Development 1996;122(9):2687–96.
15 Cheng Z, Zhu Y, Su D et al. A Novel Mutation of HOXA10 in a Chinese
Woman With a Mullerian Duct Anomaly - PubMed. Hum Reprod.
2011;26(11):3197-3201.
16 Filippou P HR. Is Foetal Hyperexposure to Androgens a Cause of PCOS?
- PubMed. Hum Reprod Updat. 2017;23(4):421-432.
17 Piltonen TT, Giacobini P, Edvinsson Å, Hustad S, Lager S,
Morin-Papunen L, et al. Circulating antimüllerian hormone and steroid
hormone levels remain high in pregnant women with polycystic ovary
syndrome at term. Fertil Steril 2019;111(3):588-596.e1.
18 Maliqueo M, Lara HE, Sánchez F, Echiburú B, Crisosto N, Sir-Petermann
T. Placental steroidogenesis in pregnant women with polycystic ovary
syndrome. Eur J Obstet Gynecol Reprod Biol 2013;166(2):151–5.
19 Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al.
Novel role for anti-Müllerian hormone in the regulation of GnRH neuron
excitability and hormone secretion. Nat Commun 2016;7.
20 Tadaion Far F, Jahanian Sadatmahalleh S, Ziaei S, Kazemnejad A.
Comparison of the umbilical cord Blood’s anti-Mullerian hormone level in
the newborns of mothers with polycystic ovary syndrome (PCOS) and
healthy mothers. J Ovarian Res 2019;12(1).
21 Tata B, Mimouni N, Barbotin A, Malone S, Loyens A, Pigny P, Dewailly
D, Sundström-Poroma I, Piltonen T, Dal Bello F, Medana C, Prevot V,
Clasadonta J, Giacobini P. Elevated prenalat anti-müllerian hormone
reprograms the fetus and induces polycystic ovary syndrome in adulthood.
Nat Med 2018; 24(6): 834-846
22 Hirobe S, He WW, Lee MM, Donahoe PK. Mullerian inhibiting substance
messenger ribonucleic acid expression in granulosa and sertoli cells
coincides with their mitotic activity. Endocrinology
1992;131(2):854–62.
23 Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton
D, et al. Anti-Müllerian hormone levels in serum from human foetuses and
children: Pattern and clinical interest. In: Molecular and Cellular
Endocrinology. Elsevier Ireland Ltd; 2003. p. 55–63.
24 Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al.
Mullerian inhibiting substance in humans: normal levels from infancy to
adulthood. J Clin Endocrinol Metab 1996;81(2):571–6.
25 Kuiri-Hänninen T, Kallio S, Seuri R, Tyrväinen E, Liakka A,
Tapanainen J, et al. Postnatal developmental changes in the
pituitary-ovarian axis in preterm and term infant girls. J Clin
Endocrinol Metab 2011;96(11):3432–9.
26 Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, Cleemann L, et
al. Serum levels of anti-Müllerian hormone as a marker of ovarian
function in 926 healthy females from birth to adulthood and in 172
turner syndrome patients. J Clin Endocrinol Metab 2010;95(11):5003–10.
27 Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N CA.
The Prevalence of Congenital Uterine Anomalies in Unselected and
High-Risk Populations: A Systematic Review - PubMed. Hum Reprod Updat.
2011;17(6):761-771.
28 Hart R, Sloboda DM, Doherty DA, Norman RJ, Atkinson HC, Newnham JP,
et al. Circulating maternal testosterone concentrations at 18 weeks of
gestation predict circulating levels of antimüllerian hormone in
adolescence: A prospective cohort study. Fertil Steril
2010;94(4):1544–7.